161 related articles for article (PubMed ID: 22537807)
1. Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph.
Limwikrant W; Nagai A; Hagiwara Y; Higashi K; Yamamoto K; Moribe K
Int J Pharm; 2012 Jul; 431(1-2):237-40. PubMed ID: 22537807
[TBL] [Abstract][Full Text] [Related]
2. Effect of varying quantities of polymer on preparation and stability evaluation of carbamazepine cocrystals with dicarboxylic acid coformers.
Wasim M; Mannan A; Ullah K; Yameen MA; Latif M; Ahmad T; Ullah M; Amirzada MI; Khan HU; Maheen S; Khan SA; Jamil QA; Bin Asad MHH; Hussain I
Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1755-1761. PubMed ID: 33612458
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
5. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
6. Unintended water mediated cocrystal formation in carbamazepine and aspirin tablets.
Arora KK; Tayade NG; Suryanarayanan R
Mol Pharm; 2011 Jun; 8(3):982-9. PubMed ID: 21548636
[TBL] [Abstract][Full Text] [Related]
7. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
[TBL] [Abstract][Full Text] [Related]
8. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291
[TBL] [Abstract][Full Text] [Related]
9. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate.
Kojima T; Tsutsumi S; Yamamoto K; Ikeda Y; Moriwaki T
Int J Pharm; 2010 Oct; 399(1-2):52-9. PubMed ID: 20696223
[TBL] [Abstract][Full Text] [Related]
10. Cocrystal formation during cogrinding and storage is mediated by amorphous phase.
Jayasankar A; Somwangthanaroj A; Shao ZJ; Rodríguez-Hornedo N
Pharm Res; 2006 Oct; 23(10):2381-92. PubMed ID: 16988890
[TBL] [Abstract][Full Text] [Related]
11. Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.
Sathisaran I; Dalvi SV
AAPS PharmSciTech; 2021 Jan; 22(1):29. PubMed ID: 33404968
[TBL] [Abstract][Full Text] [Related]
12. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
13. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.
Tian F; Zhang F; Sandler N; Gordon KC; McGoverin CM; Strachan CJ; Saville DJ; Rades T
Eur J Pharm Biopharm; 2007 Jun; 66(3):466-74. PubMed ID: 17257816
[TBL] [Abstract][Full Text] [Related]
14. Understanding impact of pre-dissolved polymers on dissolution behavior of soluble carbamazepine cocrystal.
Ullah M; Khan SA; Shah SM; Rabbani I; Sadozai SK; Abbas N; Bin Asad MHH; Badshah M; Hasan SMF; Hussain I
Pak J Pharm Sci; 2019 May; 32(3):1049-1055. PubMed ID: 31278719
[TBL] [Abstract][Full Text] [Related]
15. The effect of pH on polymorph formation of the pharmaceutically active compound tianeptine.
Orola L; Veidis MV; Sarcevica I; Actins A; Belyakov S; Platonenko A
Int J Pharm; 2012 Aug; 432(1-2):50-6. PubMed ID: 22569228
[TBL] [Abstract][Full Text] [Related]
16. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
17. Quantification of a cocrystal and its dissociated compounds in solid dosage form using transmission Raman spectroscopy.
Koide T; Takeuchi Y; Otaki T; Yamamoto K; Shimamura R; Ohashi R; Inoue M; Fukami T; Izutsu KI
J Pharm Biomed Anal; 2020 Jan; 177():112886. PubMed ID: 31563757
[TBL] [Abstract][Full Text] [Related]
18. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
19. One-solvent polymorph screen of carbamazepine.
Getsoian A; Lodaya RM; Blackburn AC
Int J Pharm; 2008 Feb; 348(1-2):3-9. PubMed ID: 17945448
[TBL] [Abstract][Full Text] [Related]
20. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
